Advances in BRAF-Targeted Therapy for Metastatic Melanoma

March 28th 2019

ADT and the Risk of Major Adverse Cardiovascular Events

March 25th 2019

Evolving Treatment Landscape of BTK Inhibitors in B-Cell Malignancies

March 4th 2019

Emerging Approaches: Pancreatic Cancer Systemic Therapy

February 20th 2019

Treating Mantle Cell Lymphoma: Role of BTK Inhibition

January 18th 2019

Expert Perspective on the Treatment of Multiple Myeloma

January 17th 2019

Novel “Tissue-Agnostic” Targeted Treatment

January 14th 2019

Novel Therapeutic Agents for Acute Myeloid and Chronic Lymphocytic Leukemia

January 8th 2019

Advances in the Treatment of Relapsed/Refractory Myeloma

November 22nd 2018

Academic Focus: CAR-T Therapy for Relapsed/Refractory NHL

October 29th 2018

Clinical Update on Differentiated Thyroid Cancer

October 26th 2018

The Hunt for Predictive Markers in Metastatic Colorectal Cancer

October 22nd 2018

Evolution of The Continuum of Care for Metastatic CRC

September 28th 2018

Global Perspectives: FLT3 Inhibitors for AML

September 20th 2018

Novel Predictive Biomarkers for Non-Small Cell Lung Cancer

August 10th 2018

Combination Approaches for Metastatic Renal Cell Carcinoma

July 30th 2018

Global Perspective: CDK4/6 Inhibitors in HR+ Breast Cancer

July 26th 2018

Choosing an Endocrine Partner: Metastatic HR+ Breast Cancer

July 19th 2018

Chemo-Immunotherapy for Non-Driver Metastatic Lung Cancer

July 10th 2018

Practical Perspectives on Treatment of Advanced Gastric/GEJ Cancers

June 26th 2018